RNS Number : 3487W Renalytix AI PLC 22 April 2021 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this
RNS Number : 3466W Renalytix AI PLC 22 April 2021 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders
RNS Number : 3204W Renalytix AI PLC 22 April 2021 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this
RNS Number : 3183W Renalytix AI PLC 22 April 2021 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders
RNS Number : 2366W Renalytix AI PLC 22 April 2021 Renalytix AI plc (" RenalytixAI " or the " Company ") U.S. General Services Administration Grants 10-Year Governmentwide Contract for RenalytixAI KidneyIntelX Testing KidneyIntelX Testing Services Available to 140 U.S.
RNS Number : 9600V Renalytix AI PLC 20 April 2021 Renalytix AI plc (" RenalytixAI " or the " Company ") KidneyIntelX Demonstrates Performance and Informs Treatment Decisions in Multinational CANagliflozin CardioVAScular Assessment Study (CANVAS) Data from 1,325 CANVAS Participants with
RNS Number : 8100V Renalytix AI PLC 19 April 2021 Renalytix AI plc Director/PDMR Shareholding New York , 19 April 2021 - Renalytix AI plc (LSE : RENX) (NASDAQ: RNLX) ("RenalytixAI" or the "Company"), an artificial intelligence -enabled in vitro diagnostics company, focused on optimizing
RNS Number : 3696V Renalytix AI PLC 14 April 2021 Renalytix AI plc (" RenalytixAI " or the " Company ") RenalytixAI and Joslin Diabetes Center Build on Proprietary Kidney Biomarker Portfolio for KidneyIntelX Platform Agreement provides RenalytixAI with exclusive option to access
RNS Number : 7571U Renalytix AI PLC 08 April 2021 Renalytix AI plc (" RenalytixAI " or the " Company ") Clinical Utility Study Demonstrates Primary Care Physicians Highly Likely to Order KidneyIntelX to Inform Care Decisions Value of KidneyIntelX Testing Demonstrated by Data from 401
RNS Number : 4091U Renalytix AI PLC 06 April 2021 Renalytix AI plc (" RenalytixAI " or the " Company ") Multi-Center Study Finds KidneyIntelX 72% More Effective Than Current Standard of Care In Identifying Early-Stage Patients at High Risk for Kidney Disease Progression and Failure
